Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $27.15 million. The enterprise value is $5.96 million.
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 15.00 million shares outstanding. The number of shares has increased by 18.27% in one year.
| Current Share Class | 15.00M |
| Shares Outstanding | 15.00M |
| Shares Change (YoY) | +18.27% |
| Shares Change (QoQ) | +12.97% |
| Owned by Insiders (%) | 9.29% |
| Owned by Institutions (%) | 3.17% |
| Float | 8.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 208.81 |
| Forward PS | n/a |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 45.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.18 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -60.81 |
Financial Efficiency
Return on equity (ROE) is -221.93% and return on invested capital (ROIC) is -133.22%.
| Return on Equity (ROE) | -221.93% |
| Return on Assets (ROA) | -89.79% |
| Return on Invested Capital (ROIC) | -133.22% |
| Return on Capital Employed (ROCE) | -116.63% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | $8,125 |
| Profits Per Employee | -$1.35M |
| Employee Count | 16 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SER has paid $25,000 in taxes.
| Income Tax | 25,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.43% in the last 52 weeks. The beta is 0.10, so SER's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -69.43% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 2.90 |
| Relative Strength Index (RSI) | 47.21 |
| Average Volume (20 Days) | 120,478 |
Short Selling Information
The latest short interest is 383,983, so 2.56% of the outstanding shares have been sold short.
| Short Interest | 383,983 |
| Short Previous Month | 323,055 |
| Short % of Shares Out | 2.56% |
| Short % of Float | 4.56% |
| Short Ratio (days to cover) | 2.69 |
Income Statement
In the last 12 months, SER had revenue of $130,000 and -$21.56 million in losses. Loss per share was -$2.00.
| Revenue | 130,000 |
| Gross Profit | -13.27M |
| Operating Income | -24.44M |
| Pretax Income | -21.27M |
| Net Income | -21.56M |
| EBITDA | -24.37M |
| EBIT | -24.44M |
| Loss Per Share | -$2.00 |
Full Income StatementBalance Sheet
The company has $24.53 million in cash and $3.34 million in debt, giving a net cash position of $21.19 million or $1.41 per share.
| Cash & Cash Equivalents | 24.53M |
| Total Debt | 3.34M |
| Net Cash | 21.19M |
| Net Cash Per Share | $1.41 |
| Equity (Book Value) | 17.63M |
| Book Value Per Share | 0.85 |
| Working Capital | 20.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.20 million and capital expenditures -$84,000, giving a free cash flow of -$18.29 million.
| Operating Cash Flow | -18.20M |
| Capital Expenditures | -84,000 |
| Depreciation & Amortization | 74,000 |
| Net Borrowing | 4.91M |
| Free Cash Flow | -18.29M |
| FCF Per Share | -$1.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -18,803.08% |
| Pretax Margin | -16,358.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |